🎙️ In this weeks episode of Oncology Decoded:
Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, speak about the clinical utility of enfortumab vedotin/pembrolizumab in MIBC and other populations.
Listen here 👉 hubs.li/Q04crM-v0#blcsm#BladderCancer#Oncology | @mkbupathi@BGarmezy
Manojkumar Bupathi, MD – Rocky Mountain Cancer Centers; Christina Davis, PharmD, BCOP – University of Colorado; and
Brianna Hoffner, MSN, ANP-BC, AOCNP – University of Colorado take part in the Barriers in Practice panel at the Denver #LearnACI.